Safety Study of GMDTC Injection in Healthy Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This trial is a randomized, double-blind, single-center, single-dose escalating Phase I clinical trial designed to evaluate the safety, tolerability, and pharmacokinetic characteristics of injectable GMDTC in healthy subjects
Epistemonikos ID: 368df4d98689c58177f2a5191d94e0bf3ed6a177
First added on: May 15, 2024